NCT00305474

Identification and Treatment of the Liability to Develop Schizophrenia

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Central South University · Academic / Other
• Sex: All
• Age: 19 Years – 59 Years
• Healthy volunteers: Accepted

Summary

This study seeks to determine whether adult, non-psychotic, first-degree relatives of schizophrenic patients who show specific neurocognitive deficits and negative symptoms will show improvements in these areas following a 6-month, double-blind trial of a low dose (up to 2.0 mg) of risperidone.

Conditions

• Schizophrenia

Interventions

Type	Name	Description
DRUG	Risperidone	Risperidone will be given in low dosage to a random sample of family members of Schizophrenic patients

Timeline

• Start date: 2003-12-01
• Primary completion: 2010-01-01
• First posted: 2006-03-22
• Last updated: 2009-06-24

Locations

1 site across 1 country: China